Safety and Efficacy of BAY 50-4798 in Patients With HIV Infection
NCT00059462
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
56
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
Interleukin-2 SA
DRUG:
HAART
Sponsor
Bayer